✦ LIBER ✦

Treatment-, Patient-, and Disease-Related Factors and the Emergence of Adverse Events with Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia

✍ Scribed by Irvine, Elizabeth; Williams, Casey

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Management of adverse events associated

✍ Jabbour, E; Deininger, M; Hochhaus, A 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 423 KB

Management of adverse events associated

✍ Jabbour, E; Deininger, M; Hochhaus, A 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 58 KB

Impact of comorbidities on the treatment

✍ Gugliotta, Gabriele; Castagnetti, Fausto; Fogli, Miriam; Cavo, Michele; Baccaran 📂 Article 📅 2013 🏛 Expert Reviews 🌐 English ⚖ 320 KB

Ponatinib: A New Tyrosine Kinase Inhibit

✍ Shamroe, C. L.; Comeau, J. M. 📂 Article 📅 2013 🏛 Harvey Whitney Books Company 🌐 English ⚖ 288 KB

Uncertainty and Cost-Effectiveness Analy

✍ Rochau, U.; Sroczynski, G.; Wolf, D.; Schmidt, S.; Jahn, B.; Conrads-Frank, A.; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Outcome After Failure of Second Generati

✍ Eghtedar, Alireza; Kantarjian, Hagop; Jabbour, Elias; O'Brien, Susan; Burton, El 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 439 KB